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Evidence for the Genetic Heterogeneity of
Nephropathic Phenotypes Associated with Denys-
Drash and Frasier Syndromes
To the Editor:
The association of constitutional heterozygous muta-
tions of the Wilms tumor 1 (WT1) gene with the majority
of cases of both Denys-Drash syndrome (DDS [MIM
194080]) (Denys et al. 1967; Drash et al. 1970) and
Frasier syndrome (FS [MIM 136680]) (Frasier et al.
1964) has been well described; however, the char-
acteristic nephropathies connected with these syn-
dromes—that is, diffuse mesangial sclerosis (DMS [MIM
256370]) and focal segmental glomerulosclerosis (FSGS
[MIM 603278])—occur more commonly in early life, as
disorders confined to the kidney. It is unclear how fre-
quent WT1 gene mutations are in this population.
The WT1 gene encodes a transcription factor critical
for the normal development and function of the uro-
genital tract, reflected by the knockout-mouse homo-
logue of WT1, in which homozygous inactivation of
Wt1 causes absent kidneys and malformation of the go-
nads (Kreidberg et al. 1993). Alternative splicing results
in at least 4 different zinc-finger protein isoforms, and
the possibility of RNA editing and use of an alternative
initiation codon increases this number to 16 (Bruening
and Pelletier 1996). A correct ratio of isoforms appears
crucial for normal gene function. During renal devel-
opment, maximum WT1 expression occurs in condens-
ing mesenchyme and during the mesenchymal-epithelial
switch. In the mature nephron, WT1 expression is con-
fined to the podocytes, a highly specialized layer of ep-
ithelial cells in the glomerulus. Here it may have a role
in the maintenance of these cells, thus affecting the in-
tegrity of the glomerular filter (Pritchard-Jones et al.
1990). Accumulating evidence supports a regulatory role
for WT1 in kidney development, although little is known
about either its targets or which genetic cascades are
affected by its abnormal function.
A wide variety of WT1 mutations is seen in DDS—a
triad of intersex, nephropathy due to DMS, and Wilms
tumor—making genotype-phenotype correlation diffi-
cult even with the aid of computer programs (Jeanpierre
et al. 1998a). In contrast, FS is caused by specific intronic
point mutations that disrupt the exon 9 alternative
splice-donor site, reversing the normal WT1 / KTS
isoform ratio (Klamt et al. 1998). It is also associated
with intersex, but there is no predisposition to Wilms,
and the nephropathy typically results from FSGS. These
conditions act as human disease models of the effects of
WT1 gene mutations and provide further strong evi-
dence of WT1’s crucial role in both renal and gonadal
development. How WT1 mutations affect glomerular
development remains a matter of debate; some muta-
tions may be mediated during the progression of ne-
phrogenesis, perhaps through aberrant interactions of
WT1 with genes and proteins important for this process,
thereby causing abnormal glomerular differentiation. It
is equally possible is that the problem could lie in the
terminally differentiated, nondividing podocytes, partic-
ularly if silencing of the normal allele were to occur, as
in some tissues (e.g., placenta and brain [Jinno et al.
1994]), and if the mutant WT1 protein were incapable
of maintaining normal podocyte function. Further study
of animal models with targeted gene mutations may shed
light on this increasingly complex picture.
Jeanpierre et al. (1998b) demonstrated that 4 of their
10 patients with DMS but no other features of DDS had
mutations in exons 8 and 9 of WT1; 3 of these 4 patients
were female. One mutation, 1147TrC (F383L) in exon
9, was novel. Two other mutations, 1186GrA (D396N)
in exon 9 and 1129CrT (H377Y) in exon 8, had been
found in previously reported cases of DDS. The fourth
mutation, (4CrT) in intron 9, had been shown to
cause FS (Barbaux et al. 1997; Kikuchi et al. 1998;
Klamt et al. 1998). Schumacher et al. (1998) studied a
broader spectrum of patients with early-onset nephrotic
syndrome, to identify possible WT1 gene mutations; two
of four patients who had DMS but lacked other features
of either DDS or FS had mutations; one of them had a
newly discovered mutation, 1135GrT (G379C) in exon
8, and the other had a mutation, 1180CrT (R394W)
in exon 9, that previously had been reported described
in a case of DDS; both patients were female and were
reported to have other unspecified features consistent
with this syndrome.
We tested the hypothesis that WT1 gene mutations
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Table 1
Results and Clinical Status
Case Karyotype
Nephropathy
Syndromal
Tumor?
Genital Status
(Internal or
External)
Other Renal
or Extrarenal
Defects?
Family
History? WT1 Gene Mutation? Age at Last Follow-up
Onset of
Proteinuria
ESRF/
Dialysis? Nephrectomy? Transplant?
DMS:
1 46,XX Day 1 Yes No Yes No Female Psychomotor Yes No; exons 1–10 10 years
2 46,XX Day 1 Yes Yes, right and left Yes No Female No No No; exons 1–10 4 years
3 46,XX Day 1 Yes Yes, right and left No No Female No Yes No; exons 1–10 8 years
4 46,XY Day 1 Yes No No No Male No No No; exons 1–10 (Died at age 3 years)12
5 46,XY 11 year Yes Yes, right and left Yes No Male No No No; exons 1–10 13 years
6 46,XY 11 year Yes Yes, right and left Yes No Male No No No; exons 1–10 11 years12
7 46,XY 11 year No No No No Male No No No; exons 1–10 3 years
8 46,XX Day 1 No No No No Female Psychomotor,
hypothyroidism
No No; exons 1–10 (Died at age 7 mo)
9 46,XY 6 mo Yes No Yes No Male Pulmonary stenosis No No; exons 1–10 14 years12
10 46,XX 11 year No No No No Female Psychomotor No No; exons 1–10 (Died at age 3 years)12
11 46,XY 18 mo Yes No No No Male No No No; exons 1–10 5 years12
12 46,XX Day 1 Yes No No No Female Psychomotor ? No; exons 2–10 (Died at age 2 mo)
13 Unknown Day1 Yes No No No Female No Yes No; exons 2–10 (Died at age 7 mo)
14 46,XY Day1 No No No No Female No No Exon 4 polymorphism (Died at age 3 mo)
15 46,XX Day1 No No No No Female Psychomotor No No; exons 2–10 (Died at age 10 mo)
16 46,XY Day 1 No No No No Male Cryptorchidism? No AflIII polymorphism (Died at age 2 mo)
17 Unknown Day 1 No No No No Unknown No No No; exons 2–10 (Died at age 10 wk)
18 Unknown Day 1 No No No No Unknown No No No; exons 2–10 (Died at age 8 mo)
19 46,XX 1 year Yes No No No Female Left kidney
dysplastic
No No; exons 5, 8, 9 2 years12
20 46,XY 9 mo No No No No Male no No No; exons 5, 8, 9 14 mo
21 46,XY 12 years Yes Yes, right and left Yes Wilms Female No No Exon 9: 1180CrT
(R394W)
13 years
22 46,XY 1 year Yes Yes, right and left Yes Wilms Ambiguous No No Exon 9: 1180CrT
(R394W)
11 years12
FSGS:
23 46,XX 4 mo No No No Female No No Exons 1–10 7 years
24 46,XX 11 year ? ? ? No Female No Yes Exons 1–10 Lost to follow-up
25 46,XY 11 year ? ? ? No Male No Yes Exons 1–10 Lost to follow-up
26 46,XX Day 1 No No No No Female No Yes Exons 1–10 3 years12
27 46,XY 18 mo Yes No Yes No Male No Yes Exons 1–10 13 years
28 46,XY 11 year Yes ? Yes No Male No No Exons 1–10 7 years
29 46,XX 1 year Yes Yes, right and left No No Female Spondyloepiphyseal
dysplasia
No Exons 1–10 (Died at age 6 years)
30 46,XY 5 years 8 years No Yes Gonadoblastoma Female No ? Intron 9 5GrA 16 years
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occur in cases of DMS and of congenital/early-onset
FSGS occurring in the absence of other features of DDS
or FS. Our intent was to identify how common muta-
tions of the WT1 gene were in this population and to
begin establishing the boundaries of the DDS/FS spec-
trum of disease.
A series of 30 patients, 22 with DMS and 8 with FSGS,
were screened for mutations of WT1 (table 1). The di-
agnosis of DMS or FSGS was established on the basis
of either renal biopsy or postmortem renal histological
findings. The majority of surviving patients with DMS
were followed-up with yearly renal ultrasounds, to ex-
clude Wilms tumor. Twenty-seven of the 30 patients had
documented karyotype analysis. Congenital malforma-
tions were investigated by clinical examination and the
appropriate investigations. None of the patients with
psychomotor abnormalities were given a diagnosis of
Galloway-Mowat syndrome. Abnormalities of the in-
ternal gonads were examined by pelvic ultrasound, and
in some cases, by laparotomy. Patient 14 had an equiv-
ocal report with regard to karyotype—and, therefore,
possible intersex status—but no other features of DDS.
Two patients with DMS (patients 21 and 22) had DDS
with known 1180CrT (R394W) mutations in exon 9
and were used as positive controls. Genomic DNA was
obtained from blood of 23 patients and from paraffin-
section material in 7 patients, by standard phenol-chlo-
roform extraction methods. The two most common DDS
mutations located in exon 9 (i.e., 1180CrT [R394W],
60%; and 1186GrA [D396N], 15%) abolish an RsrII
site in zinc finger 3 (Little et al. 1993). Heterozygous
loss of the site was observed in patients 21 and 22, as
expected, whereas patients 1–20 showed normal restric-
tion-enzyme digests. We used SSCP to analyze exons
1–10 after PCR amplification, using oligonucleotides
that had also been published by Baird et al. (1992a) and
radiolabeling them with [32P]. Products were electro-
phoresed, at 4C, on both 5% and 10% nondenaturing
polyacrylamide gels. In addition, exons 5, 8, and 9 were
directly sequenced on an ABI 377 automated sequencer.
PCR products were purified either on spin columns (Pro-
mega Biotec) or by gel extraction (Qiagen Gel Extraction
Kit). Samples (2–5 ml) of the purified product were se-
quenced by use of a Thermo-Sequenase dye terminator
cycle sequencing kit and 5 pmol of the original primer.
No WT1 mutations were detected in either the 20
patients with isolated DMS or the 7 patients with iso-
lated FSGS, although patient 14 demonstrated a newly
discovered polymorphism in codon 178 CrT in exon 4,
which conserves a threonine, and patient 16 a demon-
strated previously reported (Groves et al. 1992) poly-
morphism, an ArG transition in codon 313 (arginine)
in exon 7, which destroys an AflIII restriction-enzyme
recognition site. Both DDS patients showed the expected
(as reported by Baird et al. 1992b) 1180CrT mutations
in exon 9; in addition, a 5GrA mutation in intron 9
was detected during this study in patient 30, who had
classic features of FS (previously reported by Klamt et
al. 1998).
In conclusion, when a larger, more generalized pop-
ulation of cases with DMS is examined, mutations of
WT1 are both less frequent than initial data have sug-
gested and absent in isolated FSGS. This confirms the
genetic heterogeneity of DMS and FSGS, despite the uni-
form renal histological findings seen throughout this
group of conditions. Supportive evidence comes from
linkage studies of familial FSGS, which show that the
candidate gene for this condition lies on chromosome
1q25-q31 (Fuchshuber et al. 1995). Isolated DMS and
FSGS may therefore also result from abnormalities of
other glomerular genes, perhaps downstream of WT1
and mimicking the effects of WT1 mutations seen in
DDS and FS.
We propose that, if WT1 gene mutations are present
in isolated renal DMS or FSGS, this lends strong support
to a diagnosis of DDS or FS, and the spectrum of DDS
should be broadened to include occasional cases in
which the characteristic nephropathy does occur alone.
In this situation, WT1 mutations appear more common
in phenotypic females, which affirms the less critical role
of WT1 in female gonadal development, as has been
suggested by experimental data (Nachtigal et al. 1998).
This finding also correlates with cases of FS in which
individuals with characteristic WT1 mutations in intron
9 and with a 46,XX karyotype develop nephropathy but
have no obvious gonadal abnormality (Klamt et al.
1998). Karyotype analysis remains the most important
first-line investigation in phenotypic females with iso-
lated renal DMS or FSGS; however, WT1 mutation anal-
ysis should also be considered in isolated DMS and
FSGS, since the presence of characteristic WT1 gene mu-
tations may be important in the determination of Wilms
tumor risk, especially in 46,XX individuals who may
not demonstrate any other clues for an underlying di-
agnosis of DDS.
Acknowledgments
A.B.K. is funded by a National Kidney Research Fund Twis-
tington Higgins Fellowship. We would like to thank the renal
units throughout the United Kingdom, which kindly provided
patients and clinical information for this study.
A. B. KOZIELL,1 R. GRUNDY,3 T. M. BARRATT,2,∗
AND P. SCAMBLER1
1Molecular Medicine, 2Nephrourology, 3Haematology
and Oncology Units, Institute of Child Health,
London
Koziell et al.: Letters to the Editor 1781
Electronic-Database Information
Online Mendelian Inheritance in Man (OMIM): http://
www.ncbi.nim.nih.gov/Omim (for FS [MIM 136680], DDS
[MIM 194080], DMS [MIM 256370], and FSGS [MIM
603278])
References
Baird PN, Groves N, Haber DA, Housman DE, Cowell JK
(1992a) Identification of mutations in the WT1 gene in tum-
ours from patients with the WAGR syndrome. Oncogene 7:
2141–2149
Baird PN, Santos A, Groves N, Jadresic L, Cowell JK (1992b)
Constitutional mutations in the WT1 gene in patients with
Denys-Drash syndrome. Hum Mol Genet 1:301–305
Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F,
Kuttenn F, Fekete CN, et al (1997) Donor splice site mu-
tations are responsible for Frasier syndrome. Nat Genet 17:
467–470
Bruening W, Pelletier J (1996) A non-AUG translational ini-
tiation event generates novel WT1 isoforms. J Biol Chem
271:8646–8654
Denys P, Malvaux P, van den Berghe H, Tanghe W, Proemans
W (1967) Association d’un syndrome anatomo-patholo-
gique de pseudo-hermaphrodisme masculin, d’un tumeur de
Wilms’ d’un nephropathie parenchymarteuse et d’un mo-
saicisme XX/XY. Arch Pediatr 24:729–739
Drash A, Sherman F, Harmann W, Blizzard R (1970) A syn-
drome of pseudohermaphroditism, Wilm’s tumour, hyper-
tension and degenerative renal disease. J Pediatr 76:585–593
Frasier SD, Bashore RA, Mosier HD (1964) Gonadoblastoma
associated with pure gonadal dysgenesis in monozygotic
twins. J Pediatr 64:740–745
Fuchshuber A, Jean G, Gribouval O, Gubler MC, Broyer M,
Beckmann JS, Niaudet P, et al (1995) Mapping a gene
(SRN1) to chromosome 1q25-q31 in idiopathic nephrotic
syndrome confirms a distinct entity of autosomal recessive
nephrosis. Hum Mol Genet 4:2155–2158
Groves N, Baird PN, Hogg A, Cowell JK (1992) A single base
pair polymorphism in the WT1 gene detected by single-
stranded conformational polymorphism analysis. Hum Ge-
net 90:440–442
Jeanpierre C, Beroud C, Niaudet P, Junien C (1998a) Software
and database for the analysis of mutations in the human
WT1 gene. Nucleic Acids Res 26:271–274
Jeanpierre C, Denamur E, Henry I, Cabanis M-O, Luce S,
Ce´cille A, Elion J, et al (1998b) Identification of constitu-
tional WT1 mutations, in patients with isolated diffuse mes-
angial sclerosis, and analysis of genotype/phenotype corre-
lations by use of a computerized mutation database. Am J
Hum Genet 62:824–833
Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE,
Niikawa N (1994) Mosaic and polymorphic imprinting of
the WT1 gene in humans. Nat Genet 6:305–309
Kikuchi H, Takata A, Akasaka Y, Fukuzawa R, Yoneyama H,
Kurosawa Y, Honda M, et al (1998) Do intronic mutations
affecting splicing of WT1 exon 9 cause Frasier syndrome?
J Med Genet 35:45–48
Klamt B, Koziell AB, Poulat F, Wieacker P, Scambler P, Berta
P, Gessler M (1998) Frasier syndrome is caused by defective
alternative splicing leading to an altered ratio of WT1 /
KTS splice isoforms. Hum Mol Genet 7:709-714
Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J,
Houseman DE, Jaenisch R (1993) WT1 is required for early
kidney development. Cell 74:679-691
Little MH, Williamson KA, Mannens M, Kelsey A, Gosden
C, Hastie ND, van Heyningen V (1993) Evidence that WT1
mutations in Denys-Drash syndrome patients may act in a
dominant-negative fashion. Hum Mol Genet 2:259-264
Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flan-
agan JN, Hammer GD, Ingraham HA (1998) Wilms’ tumor
1 and Dax-1 modulate the orphan nuclear receptor SF-1 in
sex-specific gene expression. Cell 93:445-454
Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Por-
teous D, Gosden C, Bard J, et al (1990) The candidate
Wilms’ tumour gene is involved in genitourinary develop-
ment. Nature 346:194-197
Schumacher V, Scharer K, Wuhl E, Altrogge H, Bonzel KE,
Guschmann M, Neuhaus TJ, et al (1998) Spectrum of early
onset nephrotic syndrome associated with WT1 missense
mutations. Kidney Int 53:1594-1600
Address for correspondence and reprints: Dr. Ania Koziell, Molecular Medi-
cine Unit, Institute of Child Health, 30 Guilford Street, London WC1N 1EH.
E-mail: A.Koziell@ich.ucl.ac.uk
*Present affiliation: Department of Oncology, The Birmingham Children’s
Hospital NHS Trust, Birmingham, England.
 1999 by The American Society of Human Genetics. All rights reserved.
0002-9297/99/6406-0032$02.00
